CCM
AGN

Copernicus Capital Management’s Allergan plc AGN Stock Holding History

Copernicus Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-15,000
Closed -$2M – 17
2018
Q4 		$2M Buy
+15,000
New +$2.46M 3.77% 12

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Copernicus Capital Management's AGN Position: Q1 2019 in Review

Copernicus Capital Management sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 15,000 shares — an estimated $2M sold.

Copernicus Capital Management first reported a position in AGN in Q4 2018 and held it in 1 quarter. The position peaked at $2M in Q4 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Copernicus Capital Management reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Copernicus Capital Management sold 15,000 Allergan plc shares in Q1 2019, an estimated $2M.
  • Copernicus Capital Management first reported a position in Allergan plc in Q4 2018 and held it in 1 quarter.
  • Copernicus Capital Management's Allergan plc position peaked at $2M in Q4 2018.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Copernicus Capital Management's 13F filing for Q1 2019, filed 15 May 2019.